CULLINAN Trademark

Trademark Overview


On Thursday, February 2, 2023, a trademark application was filed for CULLINAN with the United States Patent and Trademark Office. The USPTO has given the CULLINAN trademark a serial number of 97778211. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, March 13, 2025. This trademark is owned by Cullinan Oncology, Inc.. The CULLINAN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceuticals for the treatment of cancer; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and for use in the fields of oncology and immunology

Pharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology
cullinan

General Information


Serial Number97778211
Word MarkCULLINAN
Filing DateThursday, February 2, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, March 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements


Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceuticals for the treatment of cancer; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and for use in the fields of oncology and immunology
Goods and ServicesPharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2023
Primary Code005
First Use Anywhere DateMonday, September 30, 2019
First Use In Commerce DateMonday, September 30, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 8, 2024
Primary Code042
First Use Anywhere DateMonday, February 4, 2019
First Use In Commerce DateMonday, February 4, 2019

Trademark Owner History


Party NameCULLINAN THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameCullinan Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, February 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 31, 2023ASSIGNED TO EXAMINER
Tuesday, November 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 7, 2024FINAL REFUSAL WRITTEN
Thursday, March 7, 2024FINAL REFUSAL E-MAILED
Thursday, March 7, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, September 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, September 20, 2024NON-FINAL ACTION E-MAILED
Friday, September 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 20, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 25, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, December 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, March 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 6, 2025TEAS AMENDMENT OF USE RECEIVED
Thursday, March 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 6, 2025AMENDMENT TO USE PROCESSING COMPLETE
Thursday, March 6, 2025USE AMENDMENT FILED
Thursday, March 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 10, 2025USE AMENDMENT ACCEPTED
Monday, March 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER